Novel transcription factor to regulate differentiation of tracheal epithelial cells.
Novel transcription factor to regulate differentiation of tracheal epithelial cells.
批准号:
09672239
负责人:
KAI Hirofumi
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We previously cloned and characterized the bovine lysozyme 5A (lys 5A) promoter with the purpose of determining cis-and trans-acting elements controlling airway epithelial cell-specific expression. We found that such expression is controlled by protein binding to an ets consensus sequence located-at-46/-40 from the transcription start site. The identity of the ets-related protein responsible for gene transactivation was unknown. In the present study, we screened ets-related proteins : MEF, ESE-1, Elf-1, Ets-1, Ets-2, and PEA 3 by transient transfection into epithelial cells and fibroblasts. Results showed that among these factors, MEF most strongly stimulated transcription in lung epithelial cells (A549), colon carcinoma cells (Caco2), and skin fibrobalsts (NIH3T3). Gel shift analysis of epithelial cell nuclear extracts using a lys 5A probe including the ets binding site (-50/-31) yielded a single band with retarded mobility. This band was supershifted by an antibody directed against MEF.This indicated that MEF is present in lung epithelial cells A549 and binds to the ets binding site in the lys 5A promoter. Supporting this, we found that anti-sense MEF mRNA decreased lys 5A promoter activity. Moreover, MEF overexpression in stable transfectants increased lysozyme mRNA and protein expression. In summary, these studies provide the first information identifying a transcription factor controlling lysozyme expression in epithelial cells. As bacteria become progressively more resistant to exogenously applied antibiotics, information regarding mechanisms controlling innate immunity, such as that provided by epithelial lysozyme, may offer important new therapeutic approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
T. Kido, H. Kai, N. Hara, I. Hamamura, Y. Isohama, K. Takahama and T. Miyata: "The use of monoclonal antibodies to quantify airway mucin content in human bronchio-alveolar lavage fluid"Pharm. Pharmacol. Comm.. 4. 219-223 (1998)
T. Kido、H. Kai、N. Hara、I. Hamamura、Y. Isohama、K. Takahama 和 T. Miyata:“使用单克隆抗体定量人支气管肺泡灌洗液中气道粘蛋白含量”Pharm。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Miyata,H.Kai et al.: "Current opinion of muco-active drug research: strategies and problems" Eur.Respir.J.11. 480-491 (1998)
T.Miyata,H.Kai 等:“粘液活性药物研究的当前观点:策略和问题”Eur.Respir.J.11。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Okumuraa, H.Kai, S.Shinozawaa, Y.Isohama, and T.Miyata: "Effects of eosinophil-granule major basic protein on phosphatidylcholine secretion in rat type II pneumocytes" Am.J,Phisiol.(in press).
M.Okumuraa、H.Kai、S.Shinozawaa、Y.Isohama 和 T.Miyata:“嗜酸性粒细胞颗粒主要碱性蛋白对大鼠 II 型肺细胞磷脂酰胆碱分泌的影响”Am.J,Phisiol.(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Kai et al.: "MEF up-regulates lysozyme transcription in epithelial cells" J.Biol.Chem.(印刷中). (1999)
H.Kai 等人:“MEF 上调上皮细胞中的溶菌酶转录”J.Biol.Chem.(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Fukushima et al.: "Inhibition of glycine-induced current by morphine in nucleus tractus solitarii neurones of guinea-pigs" Meth.Find Exp.Clin.Pharmacol.20. 125-132 (1998)
H.Fukushima 等人:“吗啡对豚鼠孤束核神经元甘氨酸诱导电流的抑制”Meth.Find Exp.Clin.Pharmacol.20。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 18 条
A new preventive way on diseases using electronic chaperones as a novel concept
-
批准号:23650269
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2011
-
负责人:KAI Hirofumi
-
依托单位:
Drug development on protein misfolding diseases
-
批准号:22390015
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2010
-
负责人:KAI Hirofumi
-
依托单位:
Therapeutic principles on protein misfolding diseases
-
批准号:19390045
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2007
-
负责人:KAI Hirofumi
-
依托单位:
Development of therapeutic ways targeting molecular chaperones and ets transcription factors
-
批准号:14370748
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.77万
-
财政年份:2002
-
负责人:KAI Hirofumi
-
依托单位:
MEF plays a role in the pathogenesis of alveolar proteinosis.
-
批准号:11672174
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:KAI Hirofumi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
METTL14通过MEF2C m6A修饰改善慢性应激致认知障碍的作用机制研究
-
批准号:2026JJ50273
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:徐杨
-
依托单位:
超级增强子NFIX-SE募集MEF2C激活NFIX/NOTCH通路增强肿瘤细胞干性导致小细胞肺癌化疗耐药的机制研究
-
批准号:2026JJ81772
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:童琴
-
依托单位:
纺织产品原材料环境足迹(MEF)核算及工具开发
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邵智娟
-
依托单位:
核纤层蛋白PRR14通过转录因子MEF2C维持骨骼肌纤维稳态并参与肌少症的发生发展
-
批准号:2025JJ50154
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:杨眉
-
依托单位:
MEF2C通过改善内皮屏障功能减轻川崎病冠脉损伤的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈志伟
-
依托单位:
胰岛素通过MEF2C-TLR4通路使脓毒血症时巨噬细胞过度激活致心肌损伤的机制研究
-
批准号:JCZRYB202500363
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
成肌样肿瘤周细胞通过p300乙酰化修饰MEF2D介导肺癌免疫抑制型围血管生态位形成的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:白雪
-
依托单位:
2 型糖尿病血管钙化新机制 :巨噬细胞外泌体Mef2d 抑制
ArsR 活化肠道脆弱拟杆菌
-
批准号:2024JJ6407
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陈聪
-
依托单位:
成纤维细胞生长因子 7 通过 SOX10/Mef2c 改善
急性心肌梗死的机制研究
-
批准号:Y24H020033
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:官学强
-
依托单位:
SIK1通过HDAC5/MEF2A/SLC7A11轴促进胰腺癌细胞抵抗铁死亡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:潘卫东
-
依托单位: